Publications
25 publications
Funding
1 grant
Completed grants (1)
- PI1-18-PMF-032Role of the alternative complement pathway in pancreatic islet physiology and the pathogenesis of type 2 diabetesAmerican Diabetes Association · 2018–2020Fellowship
News mentions
2 mentionsView all WCM news ↗
- Researchers Discover a Blood-Pressure Drug May Stimulate “Healthy” Brown FatOctober 19, 2026
Losartan, a drug commonly prescribed for high blood pressure, boosts brown adipose tissue or “brown fat” activity and enhances its metabolism, according to a preclinical study by Weill Cornell Medicine, Rockefeller University and Memorial Sloan Kettering Cancer Center researchers.
- Researchers Find New Potential Approach to Type 2 Diabetes TreatmentNovember 7, 2019
The protein adipsin, which is produced in body fat, helps protect insulin-secreting cells called pancreatic beta cells from destruction in type 2 diabetes, according to a new study by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Media highlights
1 clip
- Common Blood Pressure Drug May Activate The Body’s Calorie-Burning FatEarth.com · November 4, 2026